Stay updated on Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 18, 2025.SummaryDifference0.6%
- Check45 days agoChange DetectedThe page has been updated to reflect a new completion status and a revised date of March 18, 2025, while the previous status of 'Active, not recruiting' and the date of February 10, 2025, have been removed.SummaryDifference1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check80 days agoChange DetectedThe webpage has updated a date from November 12, 2024, to February 10, 2025.SummaryDifference0.9%
Stay in the know with updates to Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial page.